Would you consider precedex as a fairly ideal drug for administering deep sedation for short-term outpatient procedures (<1 hours on healthy young adult patients ASA1)? It's one of the few drugs that avoids respiratory depression while providing sedation, hypnosis, and analgesia making it ideal for providers with training less than that of anesthesiologist to provide outpatient sedation. I think one of the few drawbacks is the cost of $40/vial. However, with the patent expiring in 2019, I would think costs would reduce and it would quickly replace propofol and ketamine.